Latest filing published 14 Jan 2025 for bioAffinity Technologies, Inc..
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
James Michael Edwards: trading record in brief
James Michael Edwards appears in our data through filings on bioAffinity Technologies, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 1 September 2022 to 10 January 2025, the count stands at 5 filings.
The open-market record is one-sided, with 1 purchase and not one sale. The totals do not cover 1 filing with an undisclosed amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 3 share grants.
The latest filing, published on 14 January 2025, reports a share grant in bioAffinity Technologies, Inc. The most recent open-market purchase was published on 29 November 2022, 1,440 days ago. Typically, a trade is published a median of 48 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to James Michael Edwards
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 6,172 shares0Common StockSEC:0001493152-25-002146:0
- 100,000 shares0Common StockSEC:0001493152-24-043707:0
- 2,243 shares@ US$4.20100.0% of flowCommon Stock, par value $0.007SEC:0001493152-22-033932:1
- 3,619 shares0Common Stock, par value $0.007SEC:0001493152-22-033932:2
- 2,448 sharesCommon Stock, par value $0.007SEC:0001493152-22-033932:0Canonical exit: 30 Nov 2022 (T+90)
5 of 5 declarations